Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Transdermal immunotherapy: Past, present and future.
Enhancing our understanding of white matter changes in early multiple sclerosis.
A Comparison of Stated Preferences for Injectable Disease-Modifying Treatments for Multiple Sclerosis: Compliant Vs. Non-Compliant Patients.
Role of Sortilin in Models of Autoimmune Neuroinflammation.
Data Quality Challenges in Systemic Lupus Erythematosus Trials: How Can This Be Optimized?
Anti-neuropathic effects of Rosmarinus officinalis L. terpenoid fraction: relevance of nicotinic receptors.
Influence of Formal Education on Cognitive Reserve in Patients with Multiple Sclerosis.
The need for a disease-specific prospective pregnancy registry for multiple sclerosis (MS).
Age-specific localization of NMDA receptors on oligodendrocytes dictates axon function recovery after ischemia.
Pediatric multiple sclerosis.
The adaptive immune response in celiac disease.
Fluctuating neurological symptoms in demyelinating disease mimicking an acute ischaemic stroke.
Increased expression ratio of matrix metalloproteinase-9 (MMP9) and tissue inhibitor of matrix metalloproteinase (TIMP-1) RNA levels in Iranian multiple sclerosis patients.
Microglial priming through the lung-brain axis: the role of air pollution-induced circulating factors.
The hGFAP-driven conditional TSPO knockout is protective in a mouse model of multiple sclerosis.
Considering depression as a consequence of activation of the inflammatory response system.
Impact of Ongoing National Health Technology Assessment Challenges on Patient Access to New Therapies for Multiple Sclerosis In Germany And The Uk.
Using A Mixed Methods Approach to Develop A Discrete Choice Experiment In Multiple Sclerosis.
Treatment adherence in multiple sclerosis: a survey of Belgian neurologists.
A review of genome-wide association studies for multiple sclerosis: classical and hypothesis-driven approaches.
Experimental autoimmune encephalomyelitis and age-related correlations of NADPH oxidase, MMP-9, and cell adhesion molecules: The increased disease severity and blood-brain barrier permeability in middle-aged mice.
Anxiety, depression and fatigue at 5-year review following CNS demyelination.
[Encephalopathy and neuromyelitis optica: the importance of recognising atypical symptoms].
Inhibitor IκBα promoter functional polymorphisms in patients with multiple sclerosis.
Gram-negative bacterial molecules associate with Alzheimer disease pathology.
Pages
« first
‹ previous
…
717
718
719
720
721
722
723
724
725
…
next ›
last »